We Jay Therapeutics Private Limited - Company Profile

It is a chemicals private limited company based in Gandhinagar, Gujarat, India, established in 2020.
2020 Gandhinagar, Gujarat, India Struck Off
Last Updated:
Access Report
About We Jay Therapeutics Private Limited

We Jay Therapeutics Private Limited, a struck off private limited company, was established on 14 February 2020 in Gandhinagar, Gujarat, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24299GJ2020PTC112714. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Sanjay Muljibhai Thakkar (Director), Sangeet Sanjaykumar Thakkar (Director). Past directors included Vijay Sureshbhai Thakkar. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Plot No. 944/2 Sector 7-C Gandhinagar, Gandhinagar, Gujarat, 382007.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299GJ2020PTC112714

  • Registration Number

    112714

  • Incorporation Date

    14 February 2020

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 1 Month
  • Last Filing with ROC 31 Mar 2021
Company report

We Jay Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into We Jay Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at We Jay Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Sanjay Muljibhai Thakkar Director 14 Feb 2020 Current
Sangeet Sanjaykumar Thakkar Director 15 Apr 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 24 Apr 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of We Jay Therapeutics.

Enhance accessibility to We Jay Therapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

We Jay Therapeutics revenue growth over time
We Jay Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of We Jay Therapeutics?

Unlock access to We Jay Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at We Jay Therapeutics?

Unlock and access historical data on people associated with We Jay Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of We Jay Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped We Jay Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on We Jay Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    We Jay Therapeutics Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    The activity Sangeet Sanjaykumar Thakkar was appointed as a Director was appointed as a Director on 15 Apr 2021 & has been associated with this company since 4 years 11 months . was completed.

  • Balance Sheet

    Progress on We Jay Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Ahmedabad. was documented.

  • Director Appointment

    Progress on Sanjay Muljibhai Thakkar was appointed as a Director was appointed as a Director on 14 Feb 2020 & has been associated with this company since 6 years 1 month . was documented.

  • Company Incorporation

    We Jay Therapeutics Private Limited was registered on 14 Feb 2020 with Roc Ahmedabad & aged 6 years 1 month as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of We Jay Therapeutics Private Limited?

The CIN of We Jay Therapeutics Private Limited is U24299GJ2020PTC112714.

Where is We Jay Therapeutics Private Limited headquartered?

We Jay Therapeutics Private Limited is headquartered at Plot No. 944/2 Sector 7-C Gandhinagar, Gandhinagar, Gujarat, 382007.

When was We Jay Therapeutics Private Limited incorporated?

We Jay Therapeutics Private Limited was incorporated on 14 February 2020.

Who are the current directors of We Jay Therapeutics Private Limited?

The current directors of We Jay Therapeutics Private Limited are

What is the primary industry of We Jay Therapeutics Private Limited?

The primary industry of We Jay Therapeutics Private Limited is Chemicals.

Is We Jay Therapeutics Private Limited a listed company?

We Jay Therapeutics Private Limited is unlisted.

What is the capital structure of We Jay Therapeutics Private Limited?

The authorized capital of We Jay Therapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available